미국 - 영어 - NLM (National Library of Medicine)

tya pharmaceuticals - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 250 mg - cephalexin capsules usp are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by and . (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.) streptococcus pneumoniae streptococcus pyogenes otitis media due to , , , , and . streptococcus pneumoniae haemophilus influenzae staphylococcus aureus streptococcus pyogenes moraxella catarrhalis skin and skin structure infections caused by and/or . staphylococcus aureus streptococcus pyogenes bone infections caused by and/or .

미국 - 영어 - NLM (National Library of Medicine)

a-s medication solutions - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 250 mg in 5 ml - cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae and streptococcus pyogenes. cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus , streptococcus pyogenes , and moraxella catarrhalis. cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus and streptococcus pyogenes . cephalexin is indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus and proteus mirabilis. cephalexin is indicated for the treatment of genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of escherichia coli , proteus mirabilis , and klebsiella pneumoniae . to reduce the development of drug-resistant bacteria and maintain the effectiveness of cep

미국 - 영어 - NLM (National Library of Medicine)

northwind pharmaceuticals - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 500 mg - cephalexin capsules usp are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by streptococcus pneumoniae and streptococcus pyogenes. (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.) otitis media due to streptococcus pneumoniae, haemophilus influenzae, staphylococcus aureus, streptococcus pyogenes, and moraxella catarrhalis. skin and skin structure infections caused by staphylococcus aureus and/or streptococcus pyogenes. bone infections caused by staphylococcus aureus and/or proteus mirabilis. genitourinary tract infections, including acute prostatitis, caused by escherich

미국 - 영어 - NLM (National Library of Medicine)

a-s medication solutions - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 250 mg - cephalexin capsules usp are indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae and streptococcus pyogenes . cephalexin capsules usp are indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus , streptococcus pyogenes , and moraxella catarrhalis . cephalexin capsules usp are indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus and streptococcus pyogenes . cephalexin capsules usp are indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus and proteus mirabilis . cephalexin capsules usp are indicated for the treatment of genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of escherichia coli , proteus mirabilis , and klebsiella pneumoniae . to reduce the dev

미국 - 영어 - NLM (National Library of Medicine)

unit dose services - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 500 mg - cephalexin capsules usp are indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae and streptococcus pyogenes . cephalexin capsules usp are indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus , streptococcus pyogenes , and moraxella catarrhalis . cephalexin capsules usp are indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus and streptococcus pyogenes . cephalexin capsules usp are indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus and proteus mirabilis . cephalexin capsules usp are indicated for the treatment of genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of escherichia coli , proteus mirabilis , and klebsiella pneumoniae . to reduce the dev

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 300.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - bacterial infection | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | osteomyelitis | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | escherichia coli | gram negative organisms | gram positive organisms | group d streptococcus | klebsiella spp. | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | proteus spp. | pseudomonas aeruginosa | staphylococcus spp. | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 75.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 600.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 600.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - arthritis - infectious | infections of the respiratory tract | infections of the urinary tracts | infections sensitive to cefovecin | organisms sensitive to cephalexin | soft tissue infections | abscesses | acute respiratory infections | anal sacculitis | bronchiseptica | bronchitis | escherichia coli | gingivitis | group d streptococcus | klebsiella spp. | pharyngitis | pneumonia | post-parturient infections | proteus spp. | pseudomonas aeruginosa | pyoderma | septicaemia | staphylococcus spp. | tonsillitis

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 600.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | osteomyelitis | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | staphylococcus spp. | tonsillitis